Healthy babies born in Britain after scientists used DNA from three people to avoid genetic disease
On Jul. 16, 2025, eight healthy babies were born in Britain with the help of an experimental technique…
Northwestern scientists studied 174 brain samples. CTE and aging were difficult to distinguish
On Jul. 11, 2025, findings from Northwestern University study show the brain protein tied to CTE is not…
UCLA study identifies key protein that helps liver cancer resist heat-based treatment
On Jul. 10, 2025, a study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center may…
Biotechnology | Disease | FDA | Neurology | Therapeutics
FDA approves updated label for Lilly’s Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer’s disease
On Jul. 9, 2025, Eli Lilly announced that the U.S. Food and Drug Administration (FDA) has approved a…
Biotechnology | Disease | FDA | Therapeutics
Merck spends $10 billion for Verona, gaining access to its COPD medication
On Jul. 9, 2025, pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases,…
Experimental Compound Offers Potential Treatment for Rare, Often Fatal, Childhood Disease
On Jul. 9, 2025, as part of a new study, neurologists at NYU Langone Health announced they have…
KalVista Pharmaceuticals Announces FDA Approval of EKTERLY® (sebetralstat), First and Only Oral On-demand Treatment for Hereditary Angioedema
On Jul. 7, 2025, KalVista Pharmaceuticals announced that the U.S. Food and Drug Administration(FDA) has approved EKTERLY® (sebetralstat),…
Air Pollution May Contribute to Development of Lung Cancer in Never-smokers, New Study Finds
On Jul. 2, 2025, a study jointly led by researchers at the University of California San Diego and…
First human genome from ancient Egypt sequenced
On Jul. 2, 2025, researchers from the Francis Crick Institute and Liverpool John Moores University (LJMU) announces they…
Scientists create first mini-lungs with built-in blood vessels, unlocking new insights for pulmonary vascular disease
On Jul. 2, 2025, researchers from the University of California, Los Angeles (UCLA) announced they have successfully grown…
Agriculture | Biotechnology | Disease | Environmental | USDA
APHIS Deregulates First Pale Cyst Nematode-Infested Field in Program History
On Jul. 2, 2025, the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS), in partnership…
Parkinson’s drug effective in treating persistent depression
On Jun. 30, 2025, a University of Oxford led study reported that a drug used for Parkinson’s disease…
A rare form of leprosy existed in the Americas for thousands of years
On Jun. 30, 2025, a new study from an international team of researchers led by the Max Planck…
Scientists discover network of cells and genes involved in Crohn’s disease complication
On Jun. 30, 2025, the Broad Institute announced that spatial mapping reveals genes contributing to fibrosis, or scarring,…
World Microbiome Day Celebrated
On Jun. 27, 2025, today is World Microbiome Day and the Microbiota Vault, together with all participating Local…
Google DeepMind Announces AlphaGenome: AI for better understanding the genome
On Jun. 25, 2025, Google Deepmind introduce AlphaGenome, a new artificial intelligence (AI) tool that more comprehensively and…
Biotechnology | Disease | FDA | Medicine | Therapeutics
Dupixent approved in the U.S. as the only targeted medicine to treat patients with bullous pemphigoid
On Jun. 20, 2025, the US Food and Drug Administration (FDA) announced it has approved Dupixent (dupilumab) for…
Vertex Reports Positive Data for Zimislecel in Type 1 Diabetes
On Jun. 20, 2025, Vertex Pharmaceuticals announced publication of updated data from the Phase 1/2 portion of the…
Nvidia-backed AI startup SandboxAQ creates new data to speed up drug discovery
On Jun. 18, 2025, SandboxAQ, an artificial intelligence startup spun out of Alphabet’s Google and backed by Nvidia…
Deadly listeria outbreak linked to chicken alfredo fettucine sold at Kroger and Walmart
On Jun. 18, 2025, federal health officials announced a listeria food poisoning outbreak that has killed three people…
Lilly to acquire Verve Therapeutics for $1 billion to advance one-time treatments for people with high cardiovascular risk
On Jun. 17, 2025, Eli Lilly and Verve Therapeutics, a Boston-based clinical-stage company developing genetic medicines for cardiovascular…
Scientists can now target the cells at the center of ALS
On Jun. 16, 2025, the Allen Institute announced that for the first time ever, scientists have developed a…
‘Artificial pancreas’ transforming the lives of thousands of children and young people with type 1 diabetes
On Jun. 16, 2025, the National Institute for Health and Care Excellence (NICE) announced that the recommendation in…
Biotechnology | Disease | Medicine | Oncology | Therapeutics
UK Nice leads the way in approving breakthrough treatment for multiple myeloma
On Jun. 13, 2025, people in England will become the first in the world to receive belantamab mafodotin…
Pioneering cancer plasticity atlas will help predict response to cancer therapies
On Jun. 12, 2025, the Wellcome Sanger Institute, Parse Biosciences and the Computational Health Center at Helmholtz Munich…
Scientists map the first step in Alzheimer’s protein aggregation and discover clues for future therapies
On Jun. 11, 2025, researchers from the Wellcome Sanger Institute, Centre of Genomic Regulation (CRG) and Institute for…
2 patient cases of Legionella pneumonia reported
On Jun. 10, 2025, two patients treated within the past two months at the University of Washington Medical…
USC Dornsife study reveals how protein droplets help cells master difficult DNA repair
On Jun. 5, 2025, research from University of Southern California, Dornsife (USC Dornsife) scientists reveals how cells fix…
Emory study finds molecular link between air pollution and pregnancy risks
On Jun. 3, 2025, a study by Emory University researchers, published in Environmental Science & Technology, found that…
‘Definitive test’ finds exercise a potent weapon against colon cancer
On Jun. 2, 2025, a first-of-its-kind international trial provides definitive evidence that people who follow a structured exercise program…